ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

Trial Combines Drugs Against Blood Vessel Formation

October 26, 2007

Former NCAB chairman, President’s Cancer Panel member Paul Calabresi dead at 73.

October 31, 2003

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010

Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers

May 31, 2002

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979

NIH Seeking More Women, Minorities On Committees

November 9, 1979